Harding Loevner, an asset management company, released its “Global Equity Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
Keep Reading →
June 7 - Hedge Fund Investor Letters, News - Comments
In this article, we will discuss the 10 best dividend aristocrat stocks sorted by hedge fund popularity.
Keep Reading →
June 2 - Dividend Stocks, Hedge Funds, News - Comments
On May 19, AbbVie Inc. (NYSE:ABBV) announced that the US Food and Drug Administration (FDA) had approved its blood cancer therapy for adult patients.
Keep Reading →
June 1 - News - Comments
In this article, we discuss 15 growth stocks to watch in Louis Navellier's 2023 portfolio.
Keep Reading →
May 26 - Hedge Funds, News - Comments
In this piece, we will take a look at five best biotechnology stocks to buy according to hedge funds.
Keep Reading →
May 25 - News - Comments
In this article, we will take a look at 5 best healthcare dividend stocks to buy.
Keep Reading →
May 24 - Dividend Stocks, Hedge Funds, News - Comments
Berkshire Hathaway dropped Bristol-Myers Squibb Company (NYSE:BMY) in the first quarter of 2022 after years of holding.
Keep Reading →
May 21 - Business, News - Comments
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Keep Reading →
May 19 - Hedge Fund Investor Letters, News - Comments
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
Keep Reading →
May 10 - News - Comments
In this article, we will take a look at states with the lowest to highest capital gains tax rates.
Keep Reading →
May 10 - Dividend Stocks, Lists, News - Comments
In this article, we will take a look at the 5 biggest immunotherapy companies in the world.
Keep Reading →
May 9 - News - Comments
Operator: Good morning, and thank you for standing by. Welcome to the AbbVie First Quarter 2023 Earnings Conference Call.
Keep Reading →
May 4 - News, Transcripts - Comments
In this article, we take a look at the 5 largest biotech companies in the US.
Keep Reading →
April 29 - News - Comments
In this article, we discuss 5 best large-cap dividend growth stocks to buy now.
Keep Reading →
April 25 - Dividend Stocks, Hedge Funds, News - Comments
In this article, we will discuss the 5 best Fast Money stocks to buy now according to hedge funds.
Keep Reading →
April 21 - News - Comments
In this article, we discuss 5 best pharma dividend stocks to buy in 2023.
Keep Reading →
April 21 - News - Comments
Amid the current market turmoil which seems to have no end in sight, it feels weird to label anything as “safe,” especially stocks, which are spooking investors more and more...
Keep Reading →
March 30 - Hedge Funds, News - Comments
In this article, we discuss 5 best dividend aristocrats to buy now.
Keep Reading →
March 21 - News - Comments
In this article, we will take a look at the 15 most promising long-term stocks according to analysts.
Keep Reading →
March 18 - Hedge Funds, News - Comments
In this article, we discuss 5 best psychedelic stocks to buy according to hedge funds.
Keep Reading →
March 12 - News - Comments
In this article, we will discuss 5 dividend kings to buy for safe dividend growth.
Keep Reading →
March 9 - Dividend Stocks, Hedge Funds, News - Comments
In this article, we discuss 5 high-growth forever dividend stocks to buy.
Keep Reading →
March 4 - Dividend Stocks, Hedge Funds, News - Comments
In this article, we will look at the 15 large-cap stocks hedge funds are dumping.
Keep Reading →
March 4 - Hedge Funds, News - Comments
With over 50,000 employees in 70+ countries, AbbVie Inc.
Keep Reading →
March 3 - News - Comments
In this article, we will be taking a look at the top 5 drug companies in USA and their China reliance.
Keep Reading →
February 27 - News - Comments
In this article, we will discuss the 5 S&P 500 dividend aristocrats popular among hedge funds.
Keep Reading →
February 25 - News - Comments
AbbVie Inc. (NYSE:ABBV) is an American pharmaceutical company with treatments for several diseases such as psoriasis, different kinds of cancers, and arthritis, among others.
Keep Reading →
February 22 - News - Comments
In this article, we discuss the 5 best safe dividend stocks for 2023.
Keep Reading →
February 19 - Dividend Stocks, Hedge Funds, News - Comments
Operator: Good morning. Thank you for standing by. Welcome to the AbbVie Fourth Quarter 2022 Earnings Conference Call. I would now like to turn -- introduce the call to Ms.
Keep Reading →
February 13 - News, Transcripts - Comments
In this article, we take a look at 12 safe stocks to buy for the long-term according to hedge funds.
Keep Reading →
February 5 - Hedge Funds, News - Comments
In this article, we discuss 5 best dividend leaders to buy according to hedge funds.
Keep Reading →
February 3 - News - Comments
In this article, we discuss 15 cheapest dividend aristocrats right now.
Keep Reading →
February 3 - Dividend Stocks, Hedge Funds, News - Comments
Alger Capital, an investment management company, released its “Alger Spectra Fund” fourth quarter investor letter. A copy of the same can be downloaded here.
Keep Reading →
February 3 - Hedge Fund Investor Letters, News - Comments
In this article, we will take a look at the 15 largest ophthalmology companies in the world.
Keep Reading →
January 31 - Lists, News - Comments
In this article, we will discuss 10 biggest dividend kings and dividend aristocrats.
Keep Reading →
January 30 - Dividend Stocks, Hedge Funds, News - Comments
Roche Holding AG (OTC:RHHBY) is a Swiss multinational biopharmaceutical and diagnostic firm. The company’s product portfolio includes therapies for cancer, virology, and autoimmune...
Keep Reading →
January 30 - News - Comments
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Keep Reading →
January 30 - Hedge Fund Investor Letters, News - Comments
In this article, we will be taking a look at 12 cheap blue chip stocks to buy.
Keep Reading →
January 26 - Hedge Funds, News - Comments
In this article, we will be taking a look at 12 cheap biotech stocks to buy.
Keep Reading →
January 25 - Hedge Funds, News - Comments
In this article, we discuss top 5 dividend aristocrats according to hedge funds.
Keep Reading →
January 18 - Dividend Stocks, Hedge Funds, News - Comments
Despite a slowing economy, investors remain confident in dividend growth to cushion their portfolios from financial blows in terms of eroding share prices.
Keep Reading →
January 18 - Dividend Stocks, Hedge Funds, News - Comments
In this article, we discuss 5 best stocks to buy before the 2023 recession.
Keep Reading →
January 7 - Hedge Funds, News - Comments
In this article, we will look at the 5 best dividend stocks to buy according to Morgan Stanley's quant screen and how they have performed in the fourth quarter.
Keep Reading →
December 30 - Hedge Funds, News - Comments
Chevron Corporation (NYSE:CVX) is a San Ramon, California-based diversified, integrated oil company that is involved in the upstream, midstream, and downstream segments of the...
Keep Reading →
December 29 - News - Comments
In this article, we discuss top 25 high-yielding dividend champions.
Keep Reading →
December 21 - Dividend Stocks, Hedge Funds, News - Comments
Pfizer Inc. (NYSE:PFE) is a research-based, global biopharmaceutical company.
Keep Reading →
December 13 - News - Comments
In this article, we discuss 5 defensive healthcare dividend stocks to buy now.
Keep Reading →
December 12 - Dividend Stocks, Hedge Funds, News - Comments
In this article, we discuss the 5 best sectors to invest in heading into 2023.
Keep Reading →
December 12 - Hedge Funds, News - Comments
In this article, we discuss the 13 best bear market stocks to buy now.
Keep Reading →
December 4 - Hedge Funds, News - Comments
In this article, we discuss 5 best stagflation stocks to buy now.
Keep Reading →
December 1 - Hedge Funds, News - Comments